Untreatable Super TB a 'threat to millions in Africa'
Pastor Dale Morgan
Untreatable Super TB a 'threat to millions in Africa'*
By Mike Pflanz in Nairobi
Last Updated: 2:51am GMT 10/11/2006
Untreatable new strains of tuberculosis spreading unchecked through
Africa could kill millions of people and reverse years of costly efforts
to keep HIV patients alive, doctors have said.
Kenya, Tanzania and Uganda are reporting increasing numbers of cases of
drug-resistant versions of the deadly disease and they fear that these
are only the tip of the iceberg.
Patients queue in Nairobi
Patients queue for anti-tuberculosis drugs at the Blue House clinic in
the Mathare slums of Nairobi
If these strains take hold, even the newest — and most expensive — drugs
will be virtually useless as patients already weakened by HIV fall prey
to the new TB.
Health experts have given warning that the lung disease, which was such
a killer in the 19th century, was staging a comeback in Britain with 11
per cent more cases in 2005 than 2004.
The vast majority of British cases are successfully treated with a
six-month regime of cheap drugs developed in the 1950s which are still
largely effective against common TB.
However, poor health services in overcrowded and poorer populations who
do not stick to their prescriptions, combined with soaring rates of HIV,
mean that the infection is mutating in many developing countries.
.
Because TB is so easily spread through coughs and sneezes, those
mutations could get a foothold in Britain. Doctors have already
identified several cases.
Kenya has reported its first 48 cases of multi-drug resistant TB in the
past nine months, the majority clustered in Nairobi's crammed and fetid
slums. Many more are expected.
In a walled compound of single-storey blue buildings off a potholed road
running through Mathare, a slum of 300,000 people, doctors are treating
two patients for multi-drug resistant TB, known as MDR TB. They are
waiting on test results for a further five.
"Our clinic caters to 2,500 people living here, half of whom have been
tested for TB, and these few have tested positive for MDR," said Dr
Liesbet Ohler, a 31-year-old Belgian working with Medecins Sans
Frontieres. "But diagnosing it, especially if the patient also has HIV,
is time-consuming and difficult and we have no way of knowing how many
others there are out there carrying around MDR and infecting others."
This is the crux of the problem. Being diagnosed with TB carries a
stigma in countries where the infection is so closely linked with HIV
that if you have one, you are assumed to have the other.
So, many infected carriers do not seeks tests, even if they could reach
a health centre that could carry out the procedure. Of those who do take
the test and start taking the drugs, up to 10 per cent fail to finish
their treatment.
If a patient pulls out for just three days, resistance begins to build
up against the six known antibiotics that are effective against TB.
There are an estimated 50 million cases of MDR TB globally, according
the World Heath Organisation, and 300,000 new patients are infected each
year.
There are increasing cases of the even nastier "extensively
drug-resistant TB", or XDR TB, which defeats all known drug regimes.